Relay Therapeutics has amended its Certificate of Incorporation to increase the number of authorized shares of its common stock by 50%. The change was approved by stockholders at the company's 2026 Annual Meeting, providing greater flexibility for future corporate purposes such as equity financings, acquisitions, and employee compensation.
Key Details
- Authorized Shares Increased: The number of authorized shares of common stock was increased from 300,000,000 to 450,000,000.
- Stockholder Approval: The amendment was approved at the Annual Meeting of Stockholders held on June 9, 2026.
- Effective Date: The Certificate of Amendment was filed with the Secretary of State of Delaware and became effective on June 9, 2026.